US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 27.140
  • +0.470+1.76%
Close Oct 11 16:00 ET
  • 27.200
  • +0.060+0.22%
Post 19:55 ET
3.30BMarket Cap-9977P/E (TTM)

Apellis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Apellis Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 16 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 213.713M--
--2024/Q3-- / 200.331M--
Aug 1, 20242024/Q2199.685M / 191.306M--
May 7, 20242024/Q1172.325M / 164.259M--
Feb 27, 20242023/Q4146.377M / 143.592M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 213.713M--
--2024/Q3-- / 200.331M--
Aug 1, 20242024/Q2199.685M / 191.306M--
May 7, 20242024/Q1172.325M / 164.259M--
Feb 27, 20242023/Q4146.377M / 143.592M--

Unlock Free Earnings Estimates

Apellis Pharmaceuticals Earnings Reports

  • Apellis Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 1 07:07 ET

  • Apellis Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 7 07:04 ET

  • Apellis Pharmaceuticals | 10-K/A: Annual report (Amendment)

    Feb 29 17:15 ET

  • Apellis Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 27 07:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 2, 2024

    Strong Buy

    • Buy

      76.47%

    • Hold

      23.53%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Gene Editing
    Gene Editing
    Intraday+1.24%